نتایج جستجو برای: iron chelation

تعداد نتایج: 145419  

2010
Jong Wook Lee Sung-Soo Yoon Zhi Xiang Shen Arnold Ganser Hui-Chi Hsu Dany Habr Gabor Domokos Bernard Roubert John B. Porter

1The Catholic University of Korea, Seoul, South Korea; 2Seoul National University College of Medicine, Seoul, South Korea; 3Ruijin Hospital, Shanghai Second Medical University, Shanghai, China; 4Medizinische Hochschule Hannover, Hannover, Germany; 5Taipei City Hospital, Taipei, Taiwan; 6Novartis Pharmaceuticals, East Hanover, NJ; 7Novartis Pharma AG, Basel, Switzerland; and 8University College ...

Journal: :Oncotarget 2021

// Gina Abdelaal 1 and Stephany Veuger Department of Applied Sciences, Faculty Health Life Northumbria University, Newcastle upon Tyne, UK Correspondence to: Abdelaal, email: [email protected] Keywords: iron chelator; oncogenesis; selective cytotoxicity; hallmarks cancer; NDRG1 Received: September 29, 2020     Accepted: December 16, Published: January 19, 2021 ...

2015
Richard D. Horniblow Miriam Dowle Tariq H. Iqbal Gladys O. Latunde-Dada Richard E. Palmer Zoe Pikramenou Chris Tselepis Moray Campbell

Alginates are a class of biopolymers with known iron binding properties which are routinely used in the fabrication of iron-oxide nanoparticles. In addition, alginates have been implicated in influencing human iron absorption. However, the synthesis of iron oxide nanoparticles employs non-physiological pH conditions and whether nanoparticle formation in vivo is responsible for influencing cellu...

Journal: :The Journal of biological chemistry 2002
Jack T Rogers Jeffrey D Randall Catherine M Cahill Paul S Eder Xudong Huang Hiromi Gunshin Lorene Leiter Jay McPhee Satinder S Sarang Tada Utsuki Nigel H Greig Debomoy K Lahiri Rudolph E Tanzi Ashley I Bush Tony Giordano Steve R Gullans

Iron-responsive elements (IREs) are the RNA stem loops that control cellular iron homeostasis by regulating ferritin translation and transferrin receptor mRNA stability. We mapped a novel iron-responsive element (IRE-Type II) within the 5'-untranslated region (5'-UTR) of the Alzheimer's amyloid precursor protein (APP) transcript (+51 to +94 from the 5'-cap site). The APP mRNA IRE is located imm...

2015
Guillaume Grolez Caroline Moreau Bernard Sablonnière Guillaume Garçon Jean-Christophe Devedjian Sayah Meguig Patrick Gelé Christine Delmaire Regis Bordet Luc Defebvre Ioav Z Cabantchik David Devos

BACKGROUND Growing body of evidence suggests that Parkinson's disease (PD) is associated with oxidative damage via iron accumulation in the substantia nigra (SN). Low ceruloplasmin (CP)-ferroxidase activity has been identified in the SN and the cerebrospinal fluid (CSF) of patients with PD. The iron chelator, deferiprone, reduces the abnormally high levels of iron in the SN. In order to determi...

2014
Chirag A. Shah

Thalassemia Major is common in India. Every year, about 10000 new patients are diagnosed in India. Treatment requires lifelong monthly transfusions, iron chelation therapy, and other care. A large number of children die before 20 years of age, even before 10 years of age in many rural areas. Average cost of care is Rs. 15,00,000 (fifteen lac) by age 15. Cost goes up with increasing age of child...

Journal: :IDrugs : the investigational drugs journal 2007
James C Barton

Deferitrin (GT-56-252) is the first drug in a class of desferrithiocin-derived hexadentate iron chelators. Genzyme Corp is developing this compound as an oral drug for the treatment of severe iron overload in people who require repeated erythrocyte transfusion for management of chronic anemia such as beta-thalassemia major. In phase I trials in adults with beta-thalassemia, deferitrin promoted ...

2006
Hava Glickstein Rinat Ben El Gabi Link William Breuer Abraham M Konijn Chaim Hershko Abraham M. Konijn Hanspeter Nick Z. Ioav Cabantchik Charles E. Smith

Labile iron in hemosiderotic plasma and tissue are sources of iron toxicity. We compared the iron chelators deferoxamine, deferiprone and deferasirox as scavengers of labile iron in plasma and cardiomyocytes at therapeutic concentrations. This comprised: chelation of labile plasma iron (LPI) in samples from thalassemia patients; extraction of total cellular iron; accessing labile iron accumulat...

2015
Valeria Pinto Manuela Balocco Ilaria Ambaglio Giorgio Derchi Luca Malcovati Gian Luca Forni

Patients with transfusion-dependent myelodysplastic syndromes (MDS) have an increased risk of cardiac events, due to both chronic anemia and iron overload. Here, we report the recovery of cardiac function after an intensive iron chelation therapy in a MDS patient who had developed heart failure due to iron overload.

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید